← Back to catalogue

Volcano S5i Intravascular Ultracound Imaging And Pressure System

FDA 510(k)EUDAMED

Class II (US FDA 510(k))

510(k) K113486

by Volcano Corporation

Identifiers

510(k) Number
K113486 FDA 510(k)
FDA Product Code
IYO FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 892.1560 FDA 510(k)
Regulation Number
892.1560 FDA 510(k)
Advisory Committee
Radiology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The Volcano S5I Intravascular Ultrasound Imaging and Pressure System is a diagnostic device classified as an intravascular ultrasound catheter system. It combines real-time ultrasound imaging with intravascular pressure measurement to visualize and assess coronary and peripheral arteries, aiding in the evaluation of plaque composition, vessel dimensions, and hemodynamic function during interventional procedures.

This system is designed for use in cardiac catheterization laboratories and interventional radiology settings. Supplied as a sterile, single-use device, it operates within MRI-safe parameters as defined by the manufacturer’s specifications. The system includes various catheter sizes and imaging probes, requiring proper storage under controlled conditions to maintain sterility and functionality. Its regulatory authorizations include FDA 510K clearance under Special Review and compliance with the Medical Device Directive (MDD)

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDD

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Volcano Corporation

Sources (2)

  • FDA 510(k) K113486 24 fields · synced Sep 18, 2026
  • EUDAMED 1 fields · synced May 19, 2026